At CD Pharma research group, our current interests are focussed on the search for new drugs with potential beneficial effects against various chronic diseases. For this purpose, we also intend to deepen the understanding of the molecular origin of these pathologies. We base our research in an extensive track record of investigating vascular and platelet function, as well as in studying the pharmacology of cellular aging and neurodegeneration, with special attention to Alzheimer's and Parkinson's diseases. In addition, we are currently working on the study of several pancreatic chronic pathologic conditions, including pancreatitis and pancreatic ductal adenocarninome.
We have the infrastructure necessary to evaluate the potential activity of new drugs on the cardiovascular system and on blood platelets.